Skip header and navigation

10 records – page 1 of 1.

Access to information regarding drug costs

https://policybase.cma.ca/en/permalink/policy9273
Date
2008-Aug-20
Topics
Population health/ health equity/ public health
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
The Canadian Medical Association recommends that physicians be provided with ready access to information regarding drug costs so these may be factored into decisions regarding patient care.
Policy Type
Policy resolution
Last Reviewed
2015-Feb-28
Date
2008-Aug-20
Topics
Population health/ health equity/ public health
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
The Canadian Medical Association recommends that physicians be provided with ready access to information regarding drug costs so these may be factored into decisions regarding patient care.
Less detail

CMA Letter to the Senate Committee on Legal and Constitutional Affairs regarding Bill C-2, An Act to amend the Criminal Code and to make consequential amendments to other Acts

https://policybase.cma.ca/en/permalink/policy9110
Date
2008-Feb-19
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  

CMA Submission to the House of Commons Standing Committee on Health - regarding Post-Market Surveillance of Pharmaceutical Products

https://policybase.cma.ca/en/permalink/policy9112
Date
2008-Feb-28
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  

Direct-to-consumer advertising (DTCA)

https://policybase.cma.ca/en/permalink/policy188
Date
2002-Sep-30
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  
Policy Type
Policy document
Last Reviewed
2016-May-20
Date
2002-Sep-30
Replaces
Position paper on direct to consumer prescription drug advertising (1986)
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Documents
Less detail

Natural health products

https://policybase.cma.ca/en/permalink/policy9255
Date
2008-Aug-20
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
The Canadian Medical Association urges the federal minister of health to prohibit claims of the therapeutic value of natural health products for the treatment of diseases listed in Schedule A of the Food and Drug Act when the supportive evidence does not meet the evidentiary standard required of medications regulated by the Health Products and Food Branch of Health Canada.
Policy Type
Policy resolution
Last Reviewed
2015-Feb-28
Date
2008-Aug-20
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
The Canadian Medical Association urges the federal minister of health to prohibit claims of the therapeutic value of natural health products for the treatment of diseases listed in Schedule A of the Food and Drug Act when the supportive evidence does not meet the evidentiary standard required of medications regulated by the Health Products and Food Branch of Health Canada.
Less detail

A Prescription for SUFA : CMA Submission to the F/P/T Ministerial Council on Social Policy Renewal

https://policybase.cma.ca/en/permalink/policy1961
Date
2002-Oct-18
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Health systems, system funding and performance
  1 document  

Principles for providing information about prescription drugs to consumers

https://policybase.cma.ca/en/permalink/policy189
Date
2003-Mar-01
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  

Psycho-active substances and the operation of motor vehicles and industrial equipment

https://policybase.cma.ca/en/permalink/policy781
Date
1973-Jun-16
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Resolution
That the membership of the Canadian Medical Association clearly inform its patients, and the general public at large, of the hazards associated with the operation of motor vehicles, industrial equipment, etc., while under the influence of psycho-active substances, especially alcohol and antihistamines, and particularly the combination of such substances.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1973-Jun-16
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Resolution
That the membership of the Canadian Medical Association clearly inform its patients, and the general public at large, of the hazards associated with the operation of motor vehicles, industrial equipment, etc., while under the influence of psycho-active substances, especially alcohol and antihistamines, and particularly the combination of such substances.
Less detail

A Public Health Perspective on Cannabis and Other Illegal Drugs : CMA Submission to the Special Senate Committee on Illegal Drugs

https://policybase.cma.ca/en/permalink/policy1968
Date
2002-Mar-11
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  2 documents  

The Right Drugs, at the Right Times, for the Right Prices: Toward a Prescription Drug Policy for Canada : CMA Presentation to House of Commons Standing Committee on Health

https://policybase.cma.ca/en/permalink/policy1955
Date
2003-Nov-06
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
  2 documents  

10 records – page 1 of 1.